VO51.F
Energy Fuels Inc.
FrankfurtEUREQUITY
Energy
DELAYED
Last price
12.84
▼ 0.12 (0.89%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
12.96
Day high
12.84
Day low
12.84
Volume
30
Market cap
$3.21B
P/E (TTM)
—
52W range
9.02 – 24.01
Trailing performance
Returnvs SPY
1W
+1.10%
+2.5%
1M
+29.10%
+25.4%
3M
-18.35%
-21.4%
6M
-33.51%
-44.6%
YTD
-0.58%
-12.9%
1Y
+38.03%
+18.0%
3Y
+97.54%
+23.4%
5Y
+104.13%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VO51.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.07M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 4, 26 | DUVENHAGE WERNER Officer |
STOCK | 10.80K | $0 | Direct |
| Jul 8, 26 | HANSEN BRUCE DOUGLAS Director |
BUY | 4.00K | $50.78K | Direct |
| Jul 7, 26 | BHAPPU ROSS R Chief Executive Officer |
BUY | 74.00K | $967.92K | Direct |
| Jun 29, 26 | SULLIVAN SCOTT E Officer |
STOCK | 8.18K | $0 | Direct |
| Jun 24, 26 | GERMAN OSCAR ARMANDO Officer |
STOCK | 6.63K | $0 | Direct |
| Apr 10, 26 | KAPOSTASY DANIEL Officer |
SELL | 15.00K | $280.65K | Direct |
| Mar 18, 26 | KAPOSTASY DANIEL Officer |
SELL | 25.00K | $471.00K | Direct |
| Mar 13, 26 | KAPOSTASY DANIEL Officer |
CONVERSION | 7.20K | $28.01K | Direct |
| Mar 10, 26 | HIGGS DENNIS LYLE Director |
SELL | 14.00K | $280.80K | Direct |
| Mar 9, 26 | FILAS BARBARA APPELIN Director |
SELL | 5.00K | $97.55K | Direct |
| Mar 2, 26 | MOORE CURTIS H. Officer |
CONVERSION | 23.77K | $506.69K | Direct |
| Mar 2, 26 | MOORE CURTIS H. Officer |
SELL | 10.00K | $231.18K | Direct |
| Jan 27, 26 | CHALMERS MARK STEPHEN Chief Executive Officer |
STOCK | 38.29K | $0 | Direct |
| Jan 27, 26 | ESHLEMAN BENJAMIN III Director |
STOCK | 5.04K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BHAPPU ROSS R |
Chief Executive Officer | 256.58K | Purchase |
BOVAIRD J BIRKS |
Director | 183.00K | Stock Award(Grant) |
CHALMERS MARK STEPHEN |
Chief Executive Officer | 909.32K | Stock Award(Grant) |
ESHLEMAN BENJAMIN III |
Director | 216.24K | Stock Award(Grant) |
FILAS BARBARA APPELIN |
Director | 160.26K | Sale |
FRYDENLUND DAVID C. |
Officer | 629.48K | Stock Award(Grant) |
HANSEN BRUCE DOUGLAS |
Director | 313.84K | Purchase |
HIGGS DENNIS LYLE |
Director | 151.11K | Sale |
KIRKWOOD ROBERT WILLIAM |
Director | 690.96K | Stock Award(Grant) |
NAZARENUS DEE ANN |
Officer | 160.22K | Sale |
Fundamentals
Market cap$3.21B
Enterprise value$2.98B
Revenue (TTM)$105.76M
Gross profit$43.20M
EBITDA$-71.67M
Net income$-81.75M
EPS (TTM)$-0.28
Free cash flow$-87.71M
Total cash$936.75M
Total debt$678.34M
Book value / share$2.60
Shares outstanding249.97M
Float248.20M
Short % of float—
Dividend yield—
Beta (5Y)1.57
Valuation & profitability ratios
Trailing P/E—
Forward P/E-98.77
PEG ratio—
Price / sales—
Price / book4.93
EV / revenue28.22
EV / EBITDA-41.64
Gross margin40.85%
Operating margin-79.03%
Profit margin-77.30%
Return on equity-11.45%
Return on assets-4.65%
Debt / equity85.13
Current ratio27.90
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $65.92M | $78.11M | $37.93M | $12.52M | -15.6% |
| Operating revenue | $65.92M | $78.11M | $37.93M | $12.52M | -15.6% |
| Cost of revenue | $52.17M | $55.92M | $18.18M | $7.84M | -6.7% |
| Gross profit | $13.75M | $22.20M | $19.75M | $4.67M | -38.0% |
| Selling, general & admin | $64.78M | $36.60M | $27.91M | $25.49M | +77.0% |
| Total operating expense | $114.91M | $59.37M | $52.11M | $49.61M | +93.6% |
| Operating income | -$101.16M | -$37.17M | -$32.37M | -$44.94M | -172.1% |
| Net interest income | $2.01M | $5.86M | $5.70M | -$166.00K | -65.7% |
| Pre-tax income | -$87.09M | -$48.21M | $100.03M | -$59.94M | -80.6% |
| Tax provision | -$979.00K | -$372.00K | $276.00K | $0 | -163.2% |
| Net income | -$85.63M | -$47.77M | $99.86M | -$59.85M | -79.3% |
| Net income to common | -$85.63M | -$47.77M | $99.86M | -$59.85M | -79.3% |
| Basic EPS | -0.38 | -0.28 | 0.63 | -0.38 | -35.7% |
| Diluted EPS | -0.38 | -0.28 | 0.62 | -0.38 | -35.7% |
| EBIT | -$101.16M | -$37.17M | -$32.37M | -$59.78M | -172.1% |
| EBITDA | -$95.72M | -$34.05M | -$29.62M | -$56.51M | -181.2% |
| Basic shares | 224.72M | 171.96M | 159.11M | 157.34M | +30.7% |
| Diluted shares | 224.72M | 171.96M | 160.15M | 157.34M | +30.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $64.74M | $38.60M | $57.45M | $62.82M | +67.7% |
| Cash & short-term investments | $861.84M | $119.46M | $190.49M | $75.01M | +621.5% |
| Accounts receivable | $15.99M | $29.02M | $406.00K | $519.00K | -44.9% |
| Inventory | $73.49M | $66.50M | $38.87M | $38.16M | +10.5% |
| Total current assets | $958.67M | $230.19M | $232.69M | $135.59M | +316.5% |
| Property, plant & equipment | $382.06M | $333.52M | $145.70M | $97.58M | +14.6% |
| Goodwill & intangibles | $4.37M | $4.77M | $0 | — | -8.4% |
| Total assets | $1.41B | $611.97M | $401.94M | $273.95M | +130.7% |
| Total current liabilities | $31.23M | $59.29M | $10.36M | $18.62M | -47.3% |
| Long-term debt | $675.69M | — | — | — | — |
| Total debt | $675.69M | $2.18M | $1.32M | $1.38M | +30,852.3% |
| Total liabilities | $729.28M | $80.29M | $22.73M | $29.54M | +808.3% |
| Retained earnings | -$489.66M | -$404.02M | -$356.26M | -$456.12M | -21.2% |
| Shareholder equity | $678.40M | $527.79M | $375.25M | $240.43M | +28.5% |
| Working capital | $927.44M | $170.90M | $222.34M | $116.97M | +442.7% |
| Net tangible assets | $674.04M | $523.03M | $375.25M | $240.43M | +28.9% |
| Shares issued | 240.37M | 198.67M | 162.66M | 157.68M | +21.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$86.11M | -$47.84M | $99.76M | -$59.94M | -80.0% |
| Stock-based compensation | $12.59M | $5.41M | $4.63M | $4.64M | +132.6% |
| Change in working capital | $2.01M | -$1.17M | $3.42M | -$13.49M | +271.0% |
| Operating cash flow | -$89.48M | -$43.97M | -$15.41M | -$49.70M | -103.5% |
| Capital expenditure | -$51.79M | -$31.02M | -$44.71M | -$2.00M | -67.0% |
| Investing cash flow | -$778.05M | -$13.30M | -$23.85M | -$7.07M | -5,751.4% |
| Financing cash flow | $894.96M | $15.59M | $30.41M | $7.87M | +5,641.7% |
| Free cash flow | -$141.27M | -$75.00M | -$60.12M | -$51.70M | -88.4% |
| End cash position | $87.20M | $58.60M | $75.02M | $80.27M | +48.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $25.11M | $35.84M | $27.10M | $17.71M | $4.21M | — | -29.9% |
| Operating revenue | $25.11M | $35.84M | $27.10M | $17.71M | $4.21M | — | -29.9% |
| Cost of revenue | $10.69M | $21.48M | $17.61M | $12.78M | $3.65M | — | -50.2% |
| Gross profit | $14.42M | $14.36M | $9.50M | $4.93M | $557.00K | — | +0.4% |
| Selling, general & admin | $19.24M | $16.55M | $18.93M | $15.68M | $14.84M | — | +16.3% |
| Total operating expense | $34.26M | $28.91M | $31.62M | $31.59M | $26.73M | — | +18.5% |
| Operating income | -$19.84M | -$14.54M | -$22.12M | -$26.67M | -$26.18M | — | -36.4% |
| Net interest income | $8.75M | $1.73M | -$1.04M | $1.12M | $1.34M | — | +405.3% |
| Pre-tax income | -$33.56M | -$10.91M | -$20.89M | -$16.92M | -$21.81M | — | -207.5% |
| Tax provision | $45.00K | $48.00K | $57.00K | $84.00K | $26.00K | — | -6.3% |
| Net income | -$33.38M | -$10.84M | -$20.79M | -$16.74M | -$21.81M | — | -207.8% |
| Net income to common | -$33.38M | -$10.84M | -$20.79M | -$16.74M | -$21.81M | — | -207.8% |
| Basic EPS | -0.13 | -0.04 | — | — | -0.10 | -0.13 | -225.0% |
| Diluted EPS | -0.13 | -0.04 | — | — | -0.10 | -0.13 | -225.0% |
| EBIT | -$31.23M | -$14.54M | -$22.12M | -$26.67M | -$21.77M | — | -114.7% |
| EBITDA | -$29.56M | -$13.12M | -$20.69M | -$25.28M | -$20.43M | — | -125.3% |
| Basic shares | 249.32M | 241.55M | — | — | 219.78M | 207.71M | +3.2% |
| Diluted shares | 249.32M | 241.55M | — | — | 219.78M | 207.71M | +3.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $58.42M | $108.45M | $64.74M | $93.96M | $71.49M | — | -46.1% |
| Cash & short-term investments | $936.75M | $910.68M | $861.84M | $235.26M | $197.90M | — | +2.9% |
| Accounts receivable | $13.11M | $5.48M | $15.99M | $8.04M | $328.00K | — | +139.2% |
| Inventory | $75.04M | $69.03M | $73.49M | $74.35M | $76.50M | — | +8.7% |
| Total current assets | $1.03B | $992.72M | $958.67M | $326.91M | $288.90M | — | +4.1% |
| Property, plant & equipment | $402.78M | $391.41M | $382.06M | $364.39M | $351.09M | — | +2.9% |
| Goodwill & intangibles | $4.23M | $4.32M | $4.37M | $4.48M | $4.53M | — | -2.1% |
| Total assets | $1.53B | $1.46B | $1.41B | $758.32M | $702.47M | — | +5.1% |
| Total current liabilities | $37.03M | $36.09M | $31.23M | $28.44M | $35.67M | — | +2.6% |
| Long-term debt | $677.68M | $676.69M | $675.69M | — | — | — | +0.1% |
| Total debt | $677.68M | $676.69M | $675.69M | — | — | $2.18M | +0.1% |
| Total liabilities | $736.40M | $731.35M | $729.28M | $50.75M | $57.70M | — | +0.7% |
| Retained earnings | -$533.88M | -$500.50M | -$489.66M | -$468.87M | -$452.13M | — | -6.7% |
| Shareholder equity | $792.57M | $723.27M | $678.40M | $703.25M | $640.18M | — | +9.6% |
| Working capital | $996.01M | $956.63M | $927.44M | $298.47M | $253.23M | — | +4.1% |
| Net tangible assets | $788.34M | $718.95M | $674.04M | $698.77M | $635.65M | — | +9.7% |
| Shares issued | 249.92M | 244.41M | 240.37M | 236.87M | 229.42M | — | +2.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$33.60M | -$10.96M | -$20.94M | -$17.00M | -$21.84M | -206.6% |
| Stock-based compensation | $3.64M | $3.51M | $3.80M | $3.30M | $2.88M | +3.6% |
| Change in working capital | -$4.11M | $15.10M | $2.36M | -$9.48M | -$118.00K | -127.2% |
| Operating cash flow | -$26.07M | $8.32M | -$16.21M | -$28.50M | -$25.94M | -413.3% |
| Capital expenditure | -$12.24M | -$11.82M | -$18.95M | -$14.96M | -$9.29M | -3.6% |
| Investing cash flow | -$118.23M | -$15.10M | -$679.50M | -$23.34M | -$51.85M | -683.1% |
| Financing cash flow | $94.50M | $49.69M | $667.04M | $75.79M | $74.29M | +90.2% |
| Free cash flow | -$38.31M | -$3.49M | -$35.16M | -$43.45M | -$35.23M | -996.9% |
| End cash position | $81.26M | $131.10M | $87.20M | $116.62M | $91.84M | -38.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $53.03M | +113.0% |
| Next quarter | — | — | $57.45M | +54.9% |
| Current year | — | — | $180.87M | +100.6% |
| Next year | — | — | $358.92M | +98.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.23%
Held by institutions78.95%
Institutions holding495
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.63
+1.64% from price
SMA 20
11.69
+9.88% from price
SMA 50
11.85
+8.37% from price
SMA 100
14.03
-8.46% from price
SMA 200
14.96
-14.15% from price
EMA 12
12.34
+4.08% from price
EMA 26
11.98
+7.17% from price
EMA 50
12.30
+4.42% from price
RSI (14)
57.0
Neutral
MACD (12,26,9)
0.36
Hist 0.15
ATR (14)
0.67
5.23% of price
Realised vol 30D
75.2%
Annualised
Bollinger upper
14.05
20, 2σ
Bollinger lower
9.32
20, 2σ
50 / 200 cross
Death
11.85 vs 14.96
Trend bias
Below 200
-14.15%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.27
Less volatile than market
Correlation to SPY
-0.04
Largely independent
Realised vol 30D
75.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-59.3%
Peak to trough
Max drawdown 5Y
-69.6%
Peak to trough
ATR 14
0.67
5.23% of price
Beta (reported)
1.57
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 26 | BMO Capital | INITIATED | — | Outperform |
| Aug 10, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jun 22, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 12, 26 | Goldman Sachs | MAINTAINED | Buy | Buy |
| May 8, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Feb 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Feb 11, 26 | Goldman Sachs | INITIATED | — | Buy |
| Jan 28, 26 | Roth Capital | UPGRADE | Sell | Neutral |
| Jan 20, 26 | B. Riley Securities | MAINTAINED | Buy | Buy |
| Jan 9, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 5, 25 | Roth Capital | DOWNGRADE | Neutral | Sell |
| Nov 4, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:50
Split dateNov 5, 2013
Headlines
Oleria and Happiest Minds Partner to Accelerate Modern Identity Governance for AI-First Enterprises
ACCESS Newswire · 7m ago
Vicore Pharma to Present at the European Respiratory Society Congress 2026
ACCESS Newswire · 7m ago
Dollar trading near multi-month lows, restrained by debt nerves
Reuters · 7m ago
Billionaire Investor Stanley Druckenmiller Sold Broadcom, Intel, and Micron and Bought Another Chip Stock That Expects to Double Data Center Sales in 2027
Motley Fool · 17m ago
TME Pharma provides update on its activities
GlobeNewswire · 17m ago
American Chemical Society Names Syngenta's Camilla Corsi the 2026 Winner of Prestigious International Award for Research in Agrochemicals
Business Wire · 22m ago
Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors
Business Wire · 22m ago
Board Update
GlobeNewswire · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.